JoVE Logo
Faculty Resource Center

Sign In

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy Video (Video) | JoVE

DOI :

10.3791/57201-v

June 1st, 2019

June 1st, 2019

16,566 Views

1Department of Surgical Oncology, Dharmais Cancer Hospital, 2Department of Anatomical Pathology, Dharmais Cancer Hospital

In Indonesia, sentinel node biopsy (SNB) is not routinely performed for breast cancer surgery because of the limitation to provide radioisotope tracer and isosulfan or patent blue dye (PBD). To overcome this obstacle, we applied 1% methylene blue dye (MBD) as a single agent to map the sentinel nodes (SNs).

-- Views

Related Videos

article

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures Video (Video) | JoVE

article

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema Video (Video) | JoVE

article

Application of Laser Micro-irradiation for Examination of Single and Double Strand Break Repair in Mammalian Cells Video (Video) | JoVE

article

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal Video (Video) | JoVE

article

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model Video (Video) | JoVE

article

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer Video (Video) | JoVE

article

Using Computer-based Image Analysis to Improve Quantification of Lung Metastasis in the 4T1 Breast Cancer Model Video (Video) | JoVE

article

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System Video (Video) | JoVE

article

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells Video (Video) | JoVE

article

Mammary Epithelial and Endothelial Cell Spheroids as a Potential Functional In vitro Model for Breast Cancer Research Video (Video) | JoVE

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved